Thyroid Hormone Transporters in Pregnancy and Fetal Development

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Dec 11

PMID 36499435

Authors

Zhongli Chen

Marcel E Meima

Robin P Peeters

W Edward Visser

Affiliations

Soon will be listed here.

Abstract

Thyroid hormone is essential for fetal (brain) development. Plasma membrane transporters control the intracellular bioavailability of thyroid hormone. In the past few decades, 15 human thyroid hormone transporters have been identified, and among them, mutations in monocarboxylate transporter (MCT)8 and organic anion transporting peptide (OATP)1C1 are associated with clinical phenotypes. Different animal and human models have been employed to unravel the (patho)-physiological role of thyroid hormone transporters. However, most studies on thyroid hormone transporters focus on postnatal development. This review summarizes the research on the thyroid hormone transporters in pregnancy and fetal development, including their substrate preference, expression and tissue distribution, and physiological and pathophysiological role in thyroid homeostasis and clinical disorders. As the fetus depends on the maternal thyroid hormone supply, especially during the first half of pregnancy, the review also elaborates on thyroid hormone transport across the human placental barrier. Future studies may reveal how the different transporters contribute to thyroid hormone homeostasis in fetal tissues to properly facilitate development. Employing state-of-the-art human models will enable a better understanding of their roles in thyroid hormone homeostasis.

Citing Articles

Lower Free Triiodothyronine is a Risk Factor of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus.

Chen Y, Sun L, Chen M, Zhang H, Song B, Wang H Diabetes Metab Syndr Obes. 2024; 17:4407-4415.

PMID: 39619225 PMC: 11606156. DOI: 10.2147/DMSO.S489204.

Thyroid dysfunction in women with a menopausal syndrome.

Pavlovska O, Savelyeva O, Pavlovska K Prz Menopauzalny. 2024; 23(3):145-151.

PMID: 39464495 PMC: 11504480. DOI: 10.5114/pm.2024.143481.

Two novel in vitro assays to screen chemicals for their capacity to inhibit thyroid hormone transmembrane transporter proteins OATP1C1 and OAT4.

Wagenaars F, Cenijn P, Chen Z, Meima M, Scholze M, Hamers T Arch Toxicol. 2024; 98(9):3019-3034.

PMID: 38761188 PMC: 11324666. DOI: 10.1007/s00204-024-03787-2.

Gestational hypothyroxinemia induces ASD-like phenotypes in behavior, proinflammatory markers, and glutamatergic protein expression in mouse offspring of both sexes.

Gonzalez-Madrid E, Rangel-Ramirez M, Opazo M, Mendez L, Bohmwald K, Bueno S Front Endocrinol (Lausanne). 2024; 15:1381180.

PMID: 38752179 PMC: 11094302. DOI: 10.3389/fendo.2024.1381180.

Recent insights into the role of hormones during development and their functional regulation.

Aref Y, Fat S, Ray E Front Endocrinol (Lausanne). 2024; 15:1340432.

PMID: 38318293 PMC: 10841574. DOI: 10.3389/fendo.2024.1340432.

References

Visser T . Role of sulfation in thyroid hormone metabolism. Chem Biol Interact. 1994; 92(1-3):293-303. DOI: 10.1016/0009-2797(94)90071-x. View

Groeneweg S, Peeters R, Moran C, Stoupa A, Auriol F, Tonduti D . Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial. Lancet Diabetes Endocrinol. 2019; 7(9):695-706. PMC: 7611958. DOI: 10.1016/S2213-8587(19)30155-X. View

Chan S, Hancox L, Martin-Santos A, Loubiere L, Walter M, Gonzalez A . MCT8 expression in human fetal cerebral cortex is reduced in severe intrauterine growth restriction. J Endocrinol. 2013; 220(2):85-95. PMC: 3921694. DOI: 10.1530/JOE-13-0400. View

Togawa N, Miyaji T, Izawa S, Omote H, Moriyama Y . A Na+-phosphate cotransporter homologue (SLC17A4 protein) is an intestinal organic anion exporter. Am J Physiol Cell Physiol. 2012; 302(11):C1652-60. DOI: 10.1152/ajpcell.00015.2012. View

Friesema E, Jansen J, Jachtenberg J, Visser W, Kester M, Visser T . Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol. 2008; 22(6):1357-69. PMC: 5419535. DOI: 10.1210/me.2007-0112. View

Camp J, Badsha F, Florio M, Kanton S, Gerber T, Wilsch-Brauninger M . Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. Proc Natl Acad Sci U S A. 2015; 112(51):15672-7. PMC: 4697386. DOI: 10.1073/pnas.1520760112. View

Hinz K, Neef D, Rutz C, Furkert J, Kohrle J, Schulein R . Molecular features of the L-type amino acid transporter 2 determine different import and export profiles for thyroid hormones and amino acids. Mol Cell Endocrinol. 2017; 443:163-174. DOI: 10.1016/j.mce.2017.01.024. View

Friesema E, Docter R, Moerings E, Verrey F, Krenning E, Hennemann G . Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology. 2001; 142(10):4339-48. DOI: 10.1210/endo.142.10.8418. View

Ananthanarayanan M, Ng O, Boyer J, Suchy F . Characterization of cloned rat liver Na(+)-bile acid cotransporter using peptide and fusion protein antibodies. Am J Physiol. 1994; 267(4 Pt 1):G637-43. DOI: 10.1152/ajpgi.1994.267.4.G637. View

10.

Luongo C, Dentice M, Salvatore D . Deiodinases and their intricate role in thyroid hormone homeostasis. Nat Rev Endocrinol. 2019; 15(8):479-488. DOI: 10.1038/s41574-019-0218-2. View

11.

Mao F, Wang M, Hou X, Zhou Z, Yan Y, Fang L . NTCP Deficiency Causes Gallbladder Abnormalities in Mice and Human Beings. Cell Mol Gastroenterol Hepatol. 2020; 11(3):831-839. PMC: 7851344. DOI: 10.1016/j.jcmgh.2020.09.001. View

12.

Calvo R, Jauniaux E, Gulbis B, Asuncion M, Gervy C, Contempre B . Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab. 2002; 87(4):1768-77. DOI: 10.1210/jcem.87.4.8434. View

13.

Loubiere L, Vasilopoulou E, Bulmer J, Taylor P, Stieger B, Verrey F . Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta. 2010; 31(4):295-304. DOI: 10.1016/j.placenta.2010.01.013. View

14.

Groeneweg S, van Geest F, Abaci A, Alcantud A, Ambegaonkar G, Armour C . Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study. Lancet Diabetes Endocrinol. 2020; 8(7):594-605. PMC: 7611932. DOI: 10.1016/S2213-8587(20)30153-4. View

15.

Ferrara A, Liao X, Gil-Ibanez P, Marcinkowski T, Bernal J, Weiss R . Changes in thyroid status during perinatal development of MCT8-deficient male mice. Endocrinology. 2013; 154(7):2533-41. PMC: 3689279. DOI: 10.1210/en.2012-2031. View

16.

Groeneweg S, van Geest F, Chen Z, Farina S, van Heerebeek R, Meima M . Functional Characterization of the Novel and Specific Thyroid Hormone Transporter SLC17A4. Thyroid. 2021; 32(3):326-335. DOI: 10.1089/thy.2021.0257. View

17.

Hagenbuch B, Meier P . Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest. 1994; 93(3):1326-31. PMC: 294097. DOI: 10.1172/JCI117091. View

18.

Fujiwara K, Adachi H, Nishio T, Unno M, Tokui T, Okabe M . Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology. 2001; 142(5):2005-12. DOI: 10.1210/endo.142.5.8115. View

19.

Zibara K, El Zein N, Sabra M, Hneino M, Harati H, Mohamed W . Thyroxine (T) Transfer from Blood to Cerebrospinal Fluid in Sheep Isolated Perfused Choroid Plexus: Role of Multidrug Resistance-Associated Proteins and Organic Anion Transporting Polypeptides. Front Neurol. 2017; 8:214. PMC: 5440555. DOI: 10.3389/fneur.2017.00214. View

20.

Wilpert N, Krueger M, Opitz R, Sebinger D, Paisdzior S, Mages B . Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 Expression. Thyroid. 2020; 30(9):1366-1383. DOI: 10.1089/thy.2019.0544. View